Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904 is a potent orally bioavailable MPO inhibitor. In preclinical studies, AZD590 | ||||
| 193264 | PF-06835919 ( MDK-1846 ) | 2102501-84-6 | ≧98.0% |  |
| MDK1846 is a potent ketohexokinase (KHK) inhibitor. | ||||
| 171454 | 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one | 1060810-24-3 | ≧98.0% |  |
| 1-(4-Bromo-6- methylpyridin-2- yl)ethan-1-one, CAS 1060810-24-3. | ||||
| 184163 | 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile | 1032570-98-1 | >96% |  |
| 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile is a drug intermediate. | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK | ||||
| 237071 | Flavopiridol ( Alvocidib ) | 146426-40-6 | ≧98.0% | .png) |
| Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
| 20266 | Linzagolix | 935283-04-8 | ≧98.0% |  |
| Linzagolix is a novel, orally administered GnRH receptor antagonist that potentially | ||||
| 20636 | Edecesertib ( GS-5718 ) | 2408839-73-4 | ≧98.0% | _2408839-73-4.png) |
| GS-5718 (Edecesertib) is a potent, selective, orally bioavailable IRAK4 inhibitor. | ||||
| 24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% |  |
| LXH-3-71 isnovel "molecular glue"that induces the interaction between PHGDH | ||||
| 51802 | TIC10 ( ONC201 ) | 1616632-77-9 | 99.85% |  |
| TIC10 ( ONC201 ), Bulk in stock, contact us by email for detailed quotation.ONC201/TI | ||||
| 174191 | SU5402 | 215543-92-3 | ≧98.0% |  |
| SU5402 is a fibroblast growth factor receptor (FGFR)-specific tyrosine kinase inhibit | ||||
| 20509 | GLPG3667 | 2308520-97-8 | ≧98.0% |  |
| GLPG3667 is an oral potent and selective small-molecule TYK2 inhibitor in development | ||||